Skip to content

Biological impact of an intensive 21-day spa recovery program on quality of life and cell health in Parkinson’s disease

Multimodal adjuvant therapy of Parkinson's disease and its impact on quality of life and the deep proteomic network

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11301892
Enrollment
35
Registered
2026-05-12
Start date
2024-02-17
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease Nervous System Diseases

Interventions

Participants completed a 21-day inpatient multimodal PSR rehabilitation programme at the Slovak Health Spa Pieštany. The regimen totalled 63 therapeutic interventions (three sessions daily) across thr

Sponsors

Slovak Research and Development Agency
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Parkinson's disease patients with mild-to-moderate impairment, classified as Hoehn and Yahr stages 1-3

Exclusion criteria

Exclusion criteria: 1. Infectious diseases: infectious diseases transmissible to humans and being a carrier of pathogens; all diseases in the acute stage 2. Cardiovascular conditions: clinical signs of circulatory failure, post-deep vein thrombosis conditions within 3 months of recovery, post-superficial thrombophlebitis conditions within six weeks of recovery, hypertension with diastolic pressure above 16 kPa (120 mm Hg) 3. Metabolic conditions: labile or decompensated diabetes mellitus, frequently recurring profuse bleeding of any kind, cachexia (wasting syndrome) of any kind, malignant tumors during and after treatment with clinically confirmed signs of disease progression 4. Neurological and psychiatric conditions: epilepsy (except for cases where no seizures have occurred in the last year), active attacks or phases of psychosis and mental disorders with antisocial behavior or impaired communication, alcohol or drug dependency, dementia 5. General and physiological conditions: stage III urinary and fecal incontinence, enuresis nocturna (bedwetting), pregnancy, non-healing skin defects of any origin

Countries

Slovakia

Contacts

Public ContactLucia Rahelova
lucia.rahelova@uniba.sk+421 (0)43 9279698

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 30, 2026